What should a 64-year-old patient consider regarding the shingles vaccine?

The shingles vaccine, specifically the recombinant zoster vaccine (Shingrix), is recommended for adults aged 50 and older to prevent shingles and its complications. The patient, being 64 years old, falls well within the recommended age range to receive the vaccine.

One significant reason to consider getting the vaccine now is coverage. While Medicare does cover the shingles vaccine when the patient turns 65, it's important to note that commercial insurance plans often provide coverage for the vaccine before Medicare eligibility. There may be cost considerations or coverage limitations associated with waiting until the patient turns 65, particularly if there is uncertainty about whether commercial insurance will continue to provide coverage once Medicare takes effect.

By getting vaccinated now, the patient can ensure protection against shingles without the potential delays or coverage issues that could arise after turning 65. Additionally, obtaining the vaccine before reaching this age may reduce the patient's risk of developing shingles, which can have significant health implications.

Therefore, the recommendation to get vaccinated at age 64 aligns with maintaining the patient's health and ensuring appropriate coverage for the vaccination.